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Many general practitioners would suspect from their 
every day practice that musculoskeletal conditions 
such as osteoarthritis, rheumatoid arthritis and 
osteoporosis are common general practice clinical 
problems. This has been confirmed by research 
– an estimated 16.7/100 GP-patient encounters are 
for a musculoskeletal condition.1 The costs to the 
community of these conditions are high, both 
economically and because they are a significant 
cause of morbidity and mortality.2,3 Due to the high 
impact of musculoskeletal disorders, the World Health 
Organisation designated 2001–2010 as the ‘bone and 
joint decade’ and, since 2002, arthritis and related 
conditions have been an Australian National Health 
Priority Area.4
The Cochrane Collaboration
The Cochrane Collaboration is an international not-for-profit 
organisation that provides up-to-date information about the 
effects of health care by synthesising the best available 
evidence into systematic reviews.5 The collaboration 
includes a number of Cochrane review groups. The 
Cochrane Musculoskeletal Group (CMSG), established 
in 1993, has become one of the largest Cochrane review 
groups, with over 200 active researchers, health care 
professionals, and consumer representatives from 26 
countries.6 Its main focus is to synthesise the results of 
high quality studies to determine the effectiveness and 
safety of interventions for the prevention, treatment and 
rehabilitation of musculoskeletal disorders. 
 In 2005, an Australian satellite editorial office of the 
CMSG was established, based at Cabrini Hospital in 
Melbourne, Victoria. An important aim of the Australian 
CMSG is to facilitate the dissemination of the results of 
relevant Cochrane reviews to clinicians, consumers, and 
policy makers in Australia. 
Calcium supplements for children
Overview 
Because the use of complementary medicine and 
supplements in the community is high,7 GPs are 
increasingly asked to comment on the usefulness or 
otherwise of these types of interventions. 
 The increasing prevalence of osteoporosis and 
associated fractures2 means that prevention of 
osteoporosis is of great public health importance. 
About 90% of the peak bone mass reached in adult life 
accumulates in childhood,8 so there is increasing interest in 
determining whether intervening in childhood can improve 
peak bone mass.9 Calcium intake plays an important role 
in bone health9 and adequate calcium intakes are widely 
promoted. In view of this, we performed a systematic 
review to answer the question: are calcium supplements 
useful as an intervention to improve bone density in 
healthy children? The review results are given in Table 1 
and how these results might affect practice are shown in 
the case discussions in Table 2.
Conclusion
While it is clear that calcium supplementation in healthy 
children has minimal effect, the review’s results cannot 
be extrapolated to other populations, such as children 
with diseases or who are on medication affecting bone 
metabolism, or those who have a very low calcium intake 
as might be seen in children who completely avoid dairy 
products. Case-by-case assessment will be needed to 
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make decisions about the usefulness of calcium 
supplements for these children until more 
evidence to support practice becomes available 
in these populations.
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Table 2. Putting evidence into practice 
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